Category: Delcath Systems Inc.
Delcath Systems has axed its general counsel as part of ongoing restructuring and to focus more resources on clinical development. The company's 2014 results show improved net losses, largely due to cost-cutting.
Delcath (NSDQ:DCTH) said it axed its general counsel as part of ongoing restructuring, aiming to focus more financial resources on clinical development programs.
Delcath Systems adds 2 German research centers to a Phase II clinical trial of its Chemosat melphalan hepatic delivery system in treating primary liver cancer.
Delcath Systems (NSDQ:DCTH) said it added 2 German research centers to a global Phase II trial of its Chemosat melphalan hepatic delivery system in treating primary liver cancer.
Here's a look at some of the top Wall Street stories for medical device companies this week.
Wall Street flees from troubled Delcath Systems after the cancer-treatment devices maker proceeds with a 1-to-16 reverse stock split.
Shares of Delcath (NSDQ:DCTH) dropped more than 18% by the early afternoon today after the company proceeded with a 1-to-16 reverse stock split.
Here's a look at some of the top personnel stories for medical device companies this week.
The proxy war over control of the board at ConMed turned ugly this week after serious allegations surfaced against 1 of the medical device company's nominees for director.
Becton Dickinson & Co.
, Boston Scientific
, Carlyle Group
, ConMed Corp.
, Coppersmith Capital Management
, Cutera Inc.
, Delcath Systems Inc.
, Johnson & Johnson
, Kaiser Permanente Ventures
, Merck KGaA
, Millipore Corp.
, National Quality Forum
, Ortho-Clinical Diagnostics
, Premier Inc.
, Varian Medical Systems
, Voce Capital Management
Spinal devices maker Vexim appoints as its director of marketing Sandrine Carle, a veteran of spinal operations at medtech giant Medtronic.
French spinal devices maker Vexim (EPA:ALVXM) this month welcome Medtronic (NYSE:MDT) veteran Sandrine Carle as its director of marketing.
Neuro Kinetics named former Zoll Medical executive Michael Saporito as CFO.
Neuro Kinetics appointed Michael Saporito as its new CFO.
Saporito joins the Pittsburgh-based medical device company after years with LifeVest, which he helped turn around before the company was bought out by Zoll Medical.